Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ANPC AnPac Bio-Medical Science
9.450-0.590-5.88%
Trading Session
02/08 11:43 ET
High
9.890
Open
9.730
Turnover
85.40K
Low
9.450
Pre Close
10.040
Volume
8.80K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Top Premarket Decliners
07:47 AM EST, 02/01/2023 (MT Newswires) -- Invacare (IVC) shares tumbled 19.7%, adding to Tuesday's 2.3% drop. Taysha Gene Therapies (TSHA) shares declined 17.7%, erasing gains from the previous sessi
Electronic Arts, Western Digital And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today's pre-market trading session.Snap Inc. (NYSE:SNAP) shares dipped 14.6% to $9.87 in pre-market trading
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersAkanda (NASDAQ:AKAN) stock increased by 28.2% to $0.36 during Thursday's after-market session. Akanda's trading volume hit 4.1 million shares by close, accounting for 474.8% of its average volu
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersMinerva Surgical (NASDAQ:UTRS) stock moved upwards by 82.4% to $0.69 during Thursday's pre-market session. The company's market cap stands at $20.8 million. TC BioPharm (Holdings) (NASDAQ:TCBP)
AnPac Bio-Medical Science Shares Rise 12% After Investment Agreements
By Chris Wack AnPac Bio-Medical Science Co. Ltd. shares were up 12% to $8.15 after the company said that in December and January, it signed definitive investment agreements with several third party i
AnPac Bio Announces Signing of $5.2M of Definitive Investment Agreements
AnPac Bio Medical Science Company Trading Halted, Volatility Trading Pause
AnPac Bio-Medical Science In Dec 2022 & Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors; Investors Agreed To Purchase 29.7M Newly Issued Class A Ordinary Shares Of Co At A Price Of $0.175/Share
AnPac Bio-Medical Science In Dec 2022 & Jan 2023, Signed Definitive Investment Agreements With Several Third Party Investors; Investors Agreed To Purchase 29.7M Newly Issued Class A Ordinary Shares Of
PLX, PLBY and THMO Among Mid-day Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersJaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday's regular session. The current volume of 532.2K shares is 6.8% of Jaguar Health's average full-day volume over the last 100
Company Overview
More
Anpac Bio-Medical Science Co., Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China.
CEO： Dr. Chris Chang Yu
Market： NASDAQ
Listing Date： 01/30/2020
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet